As of October 22, 2019, a total of 1,604 cases of EVALI, including 34 deaths, were reported to CDC. Based on data collected as of October 15, 2019, use of tetrahydrocannabinol (THC)-containing products in the 3 months preceding symptom onset was reported by 86% of patients. The median age of EVALI patients who survived was 23 years, and the median age of EVALI patients who died was 45 years.
Interested in preventing e-cigarette use among youth?
Check out the single-session evidence-informed Vaping Prevention Plus Wellness program: https://preventionpluswellness.com/products/vaping-prevention-plus-wellness-program-1